Chiasma to Present at the Cowen and Company 37th Annual Health Care Conference
01. März 2017 08:00 ET
|
Chiasma, Inc.
WALTHAM, Mass., March 01, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic...
Chiasma Provides Year-End Corporate Update and Preliminary Outlook for 2017
09. Januar 2017 08:00 ET
|
Chiasma, Inc.
WALTHAM, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
Chiasma Provides Corporate Update and Reports Third Quarter 2016 Results
09. November 2016 16:05 ET
|
Chiasma, Inc.
WALTHAM, Mass., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
Chiasma Recognizes Acromegaly Awareness Day with New Resources for Patients and Data Presentation for Physicians
01. November 2016 08:00 ET
|
Chiasma, Inc.
Data from a Novel Patient-Reported Outcome Tool Assessing Acromegaly Treatment Satisfaction to be Presented Tools for Patients Added to Acromegaly.care WALTHAM, Mass., Nov. 01, 2016 (GLOBE...
Chiasma Names Mark J. Fitzpatrick Chief Executive Officer
30. September 2016 16:15 ET
|
Chiasma, Inc.
WALTHAM, Mass., Sept. 30, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
Chiasma Announces Workforce Reduction
16. August 2016 09:00 ET
|
Chiasma, Inc.
WALTHAM, Mass., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
Chiasma Provides Corporate Update and Reports Second Quarter 2016 Results
10. August 2016 16:02 ET
|
Chiasma, Inc.
WALTHAM, Mass., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
Chiasma to Report Second Quarter 2016 Financial Results on August 10, 2016
27. Juli 2016 08:00 ET
|
Chiasma, Inc.
WALTHAM, Mass., July 27, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
Chiasma Announces Corporate Restructuring Plan and Provides Regulatory Update Regarding Mycapssa™
14. Juni 2016 09:00 ET
|
Chiasma, Inc.
WALTHAM, Mass., June 14, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
Chiasma to Present at Jefferies Global Healthcare Conference
31. Mai 2016 08:00 ET
|
Chiasma, Inc.
WALTHAM, Mass., May 31, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company developing an investigational new drug, Mycapssa™ (octreotide) capsules, for the potential...